CCR2 anticorps (N-Term)
Aperçu rapide pour CCR2 anticorps (N-Term) (ABIN1732433)
Antigène
Voir toutes CCR2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 20-100, N-Term
-
Specificité
- Reacts with human ~42 kDa CCR2
-
Purification
- Purified
-
Immunogène
- Synthetic peptide made to an N-terminal portion of the human CCR2 protein (within residues 20-100).
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- FC : 1/50 - ICC : 1/50 - WB : 1.0 μg/mL -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS, glycerol 30 % , Sodium azide 0.1 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
- CCR2 (Chemokine (C-C Motif) Receptor 2 (CCR2))
-
Autre désignation
- C-C Chemokine Receptor Type 2 (CCR2 / CD192)
-
Sujet
- Receptor for the CCL2, CCL7 and CCL13 chemokines. Transduces a signal by increasing intracellular calcium ion levels. Alternative coreceptor with CD4 for HIV-1 infection.
-
UniProt
- P00338
-
Pathways
- cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Antigène
-